Needham & Company LLC Reaffirms Hold Rating for Fate Therapeutics (NASDAQ:FATE)
Fate Therapeutics (NASDAQ:FATE – Get Free Report)‘s stock had its “hold” rating reiterated by investment analysts at Needham & Company LLC in a research report issued on Thursday,Benzinga reports. A number of other equities research analysts have also recently issued reports on the stock. Bank of America upgraded shares of Fate Therapeutics from an “underperform” […]
Fate Therapeutics (NASDAQ:FATE – Get Free Report)‘s stock had its “hold” rating reiterated by investment analysts at Needham & Company LLC in a research report issued on Thursday,Benzinga reports. A number of other equities research analysts have also recently issued reports on the stock. Bank of America upgraded shares of Fate Therapeutics from an “underperform” […]
